» Articles » PMID: 32682453

Risk Factors for Hospitalization and Mortality Due to COVID-19 in Espírito Santo State, Brazil

Overview
Specialty Tropical Medicine
Date 2020 Jul 20
PMID 32682453
Citations 80
Authors
Affiliations
Soon will be listed here.
Abstract

Brazil is, at the time of writing, the global epicenter of COVID-19, but information on risk factors for hospitalization and mortality in the country is still limited. Demographic and clinical data of COVID-19 patients until June 11th, 2020 were retrieved from the State Health Secretariat of Espírito Santo, Brazil. Potential risk factors for COVID-19 hospitalization and death were analyzed by univariate and multivariable logistic regression models. A total of 10,713 COVID-19 patients were included in this study; 81.0% were younger than 60 years, 55.2% were female, 89.2% were not hospitalized, 32.9% had at least one comorbidity, and 7.7% died. The most common symptoms on admission were cough (67.7%) and fever (62.6%); 7.1% of the patients were asymptomatic. Cardiovascular diseases (23.7%) and diabetes (10.3%) were the two most common chronic diseases. Multivariate logistic regression analysis identified an association of all explanatory variables, except for cough and diarrhea, with hospitalization. Older age (odds ratio [OR] = 3.95, < 0.001) and shortness of breath (OR = 3.55, < 0.001) were associated with increase of odds to COVID-19 death in hospitalized patients. Our study provided evidence that older age, male gender, Asian, indigenous or unknown race, comorbidities (smoking, kidney disease, obesity, pulmonary disease, diabetes, and cardiovascular disease), as well as fever and shortness of breath increased the risk of hospitalization. For death outcome in hospitalized patients, only older age and shortness of breath increased the risk.

Citing Articles

Association between demographic, clinical characteristics and severe complications by SARS-CoV-2 infection in a community-based healthcare network in Chile.

Leniz J, Hernandez-Jana S, Soto M, Arenas E, Margozzini P, Suarez F PLoS One. 2025; 19(12):e0314376.

PMID: 39775294 PMC: 11684639. DOI: 10.1371/journal.pone.0314376.


Application of Mixture and Non-mixture Cure Models in Survival Analysis of Patients With COVID-19.

Kamalzade M, Abolghasemi J, Salehi M, Hasannezhad M, Kargarian-Marvasti S Cureus. 2024; 16(4):e58550.

PMID: 38957820 PMC: 11218444. DOI: 10.7759/cureus.58550.


Clinical and epidemiological risk factors associated with hospitalization and mortality rate of COVID-19 patients in Banja Luka County: A retrospective observational cohort study on 40,000 patients.

Pilipovic Broceta N, Todorovic N, Skrbic R, Acimovic J, Strbac S, Soldatovic I J Family Med Prim Care. 2024; 13(5):2130-2137.

PMID: 38948596 PMC: 11213400. DOI: 10.4103/jfmpc.jfmpc_1641_23.


Impact and evolution of risk factors associated with hospitalization and mortality due to COVID-19 during the six epidemic waves in Mexico.

Saldana-Jimenez F, Almaguer-Martinez F, Hernandez-Cabrera F, Morales-Vidales J, Soto-Rocha M, Walle-Garcia O Heliyon. 2024; 10(6):e27962.

PMID: 38510039 PMC: 10950712. DOI: 10.1016/j.heliyon.2024.e27962.


Predictors of mortality among inpatients in COVID-19 treatment centers in the city of Butembo, North Kivu, Democratic Republic of Congo.

Akilimali P, Kayembe D, Muhindo N, Tran N PLOS Glob Public Health. 2024; 4(1):e0002020.

PMID: 38266008 PMC: 10807785. DOI: 10.1371/journal.pgph.0002020.


References
1.
Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

2.
Zhang J, Wang X, Jia X, Li J, Hu K, Chen G . Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin Microbiol Infect. 2020; 26(6):767-772. PMC: 7159868. DOI: 10.1016/j.cmi.2020.04.012. View

3.
Honce R, Schultz-Cherry S . Impact of Obesity on Influenza A Virus Pathogenesis, Immune Response, and Evolution. Front Immunol. 2019; 10:1071. PMC: 6523028. DOI: 10.3389/fimmu.2019.01071. View

4.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

5.
Tetro J . Is COVID-19 receiving ADE from other coronaviruses?. Microbes Infect. 2020; 22(2):72-73. PMC: 7102551. DOI: 10.1016/j.micinf.2020.02.006. View